Browsing by Author Xue, R

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 3 to 11 of 11 < previous 
TitleAuthor(s)Issue DateViews
 
HFIP-induced structures and assemblies of the peptides from the transmembrane domain 4 of membrane protein Nramp1
Journal:Biopolymers - Peptide Science Section
Xue, RWang, SWang, CZhu, TLi, FSun, H
2006
177
 
Hyperglycemia-induced inhibition of DJ-1 expression compromised the effectiveness of ischemic postconditioning cardioprotection in rats
Journal:Oxidative Medicine and Cellular Longevity
Liu, MZhou, BXia, ZYZhao, BLei, S.Q.Yang, Q.J.Xue, RLeng, YXu, J.J.Xia, Z
2013
55
 
Lipopolysaccharide Induces NEAT 1 Expression in AKI via TLR4/NF-κB Signaling
Proceeding/Conference:Journal of the American Society of Nephrology
XUE, RYiu, WHLOK, SWYChan, LYYLeung, JCKLai, KNLan, HYTang, SCW
2020
8
 
Misaligned Expectations on Integrative Medical Service for Diabetes and Diabetic Kidney Disease – A Comparative Focus Group Series of Patients and Physicians
Proceeding/Conference:Global Advances in Health and Medicine
Chan, KWLee, PWLeung, CPSChan, GCWYiu, WHCheung, HMLi, BLok, WYLi, HXue, RChan, YYLeung, JCKLam, TPLai, KNTang, SCW
2020
 
Patients’ and clinicians’ expectations on integrative medicine Services for Diabetes: a focus group study
Journal:BMC Complementary Medicine and Therapies
Chan, KWLee, PWLeung, CPSChan, GCWYiu, WHCheung, HMLI, BLOK, SWYLI, HXUE, RChan, LYYLeung, JCKLam, TPLai, KNTang, SCW
2020
37
 
Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis
Journal:Frontiers in Pharmacology
Chan, KWYu, KYYiu, WHXUE, RLOK, WYLI, HZOU, YMA, JLai, KNTang, SCW
2022
 
Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways
Journal:Clinical Science
Xue, RLei, SXia, ZWu, YMeng, QZhan, LSu, WLiu, HXu, JLiu, ZZhou, BXia, Z
2016
 
The efficacy and safety of nimodipine in acute ischemic stroke patients with mild cognitive impairment: a double-blind, randomized, placebo-controlled trial
Journal:Science Bulletin
Zheng, HWang, YWang, ALi, HWang, DZhao, XWang, PShen, HZuo, LPan, YLi, ZMeng, XWang, XShi, WJu, YLiu, LDong, KWang, CSui, RXue, RPan, XNiu, XLuo, BSui, YWang, HFeng, TWang, YThe NICE trial group,
2019
44
 
The PAR-1 antagonist Vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis
Journal:Clinical Science
Lok, SWYYiu, WHLi, HXue, RZou, YLi, BChan, KWChan, LYYLeung, JCKLai, KNTang, SCW
2020
39
Showing results 3 to 11 of 11 < previous